- Home
- AUTL vs OPRX Comparison
AUTL vs OPRX Comparison
Compare AUTL & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- OPRX
- Stock Information
- Founded
- AUTL 2014
- OPRX 2006
- Country
- AUTL United Kingdom
- OPRX United States
- Employees
- AUTL N/A
- OPRX N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- OPRX Business Services
- Sector
- AUTL Health Care
- OPRX Consumer Discretionary
- Exchange
- AUTL Nasdaq
- OPRX Nasdaq
- Market Cap
- AUTL 433.8M
- OPRX 380.6M
- IPO Year
- AUTL 2018
- OPRX N/A
- Fundamental
- Price
- AUTL $1.54
- OPRX $21.79
- Analyst Decision
- AUTL Strong Buy
- OPRX Buy
- Analyst Count
- AUTL 5
- OPRX 8
- Target Price
- AUTL $9.12
- OPRX $12.19
- AVG Volume (30 Days)
- AUTL 2.8M
- OPRX 312.1K
- Earning Date
- AUTL 11-11-2025
- OPRX 11-06-2025
- Dividend Yield
- AUTL N/A
- OPRX N/A
- EPS Growth
- AUTL N/A
- OPRX N/A
- EPS
- AUTL N/A
- OPRX N/A
- Revenue
- AUTL $29,934,000.00
- OPRX $104,748,000.00
- Revenue This Year
- AUTL $641.63
- OPRX $17.92
- Revenue Next Year
- AUTL $109.21
- OPRX $10.91
- P/E Ratio
- AUTL N/A
- OPRX N/A
- Revenue Growth
- AUTL 185.17
- OPRX 25.89
- 52 Week Low
- AUTL $1.11
- OPRX $3.78
- 52 Week High
- AUTL $4.69
- OPRX $21.99
- Technical
- Relative Strength Index (RSI)
- AUTL 46.56
- OPRX 63.72
- Support Level
- AUTL $1.58
- OPRX $18.43
- Resistance Level
- AUTL $1.72
- OPRX $20.48
- Average True Range (ATR)
- AUTL 0.11
- OPRX 1.11
- MACD
- AUTL -0.01
- OPRX 0.11
- Stochastic Oscillator
- AUTL 28.57
- OPRX 93.39
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.